Status:
COMPLETED
Tacrolimus Microsampling
Lead Sponsor:
Children's Hospital Medical Center, Cincinnati
Conditions:
Validate Volumetric Absorptive Microsampling (VAMS) Assay
Eligibility:
All Genders
1-21 years
Phase:
NA
Brief Summary
This is a feasibility study at a single site, Cincinnati Children's Hospital Medical Center. Patients who have undergone heart transplantation who meet eligibility requirements will be approached to p...
Eligibility Criteria
Inclusion
- Pediatric, adolescent, or young adult patients ≥1 and ≤21 years of age
- Aim 1: All patients presenting for routine post-transplant care including, but not limited to: cardiac catheterization, cardiac biopsy, inpatient admission, or outpatient visits
- Aim 2: outpatient
- Currently taking tacrolimus
Exclusion
- Non-English-speaking patients
- Unable to access overnight delivery services (Aim 2 only)
Key Trial Info
Start Date :
October 7 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 28 2022
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT04810143
Start Date
October 7 2019
End Date
July 28 2022
Last Update
December 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cincinnati Children's Hospital
Cincinnati, Ohio, United States, 45229